QA: Crescent Biopharma INC in us_pharma/2018

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001253689_2019_Crescent_Biopharma_INC.pdf

Logs

warning The stock_price does not exist industry.us_generic {}

Graph

Absolute values for 0001253689, Crescent Biopharma INC

  xvar xval
0 AssetsCurrent 212,269,119
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 957,226
3 remainder_Assets 1,612,927
4 LiabilitiesCurrent 8,763,154
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 611,623
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 11,945,356
9 ResearchAndDevelopmentExpense 45,759,946
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 16,131,080
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 214,839,272
1 Liabilities 9,374,777
2 Expenses 57,705,302
3 Revenues 0
4 StockholdersEquity 205,464,495
5 NetIncome -41,574,222
6 ComprehensiveNetIncome -41,574,222
7 BaseVar 149,025,216
8 EconomicCapitalRatiobeforeLimitedLiability 3.62
9 EconomicCapitalRatio 4.12

Edgar->Model Mapping

Feature Distribution

Change over Time